cepedol vet. 20 mg tyggetabletter
cp pharma - tramadolhydrochlorid - tyggetabletter - 20 mg
cepedol vet. 50 mg tyggetabletter
cp pharma - tramadolhydrochlorid - tyggetabletter - 50 mg
cepedol vet. 80 mg tyggetabletter
cp pharma - tramadolhydrochlorid - tyggetabletter - 80 mg
skudexa 75+25 mg granulat til oral opløsning i brev
menarini international operation - dexketoprofentrometamol, tramadolhydrochlorid - granulat til oral opløsning i brev - 75+25 mg
skudexa 75+25 mg filmovertrukne tabletter
menarini international operation - dexketoprofentrometamol, tramadolhydrochlorid - filmovertrukne tabletter - 75+25 mg
trampalgin 37,5 mg+325 mg tabletter
karo pharma as - paracetamol, tramadolhydrochlorid - tabletter - 37,5 mg+325 mg
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
abiraterone mylan
mylan ireland limited - abiraterone acetat - prostatiske neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
venlafaxin "stada" 150 mg depotkapsler, hårde
stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 150 mg
venlafaxin "stada" 37,5 mg depotkapsler, hårde
stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg